Study summary · research use only
Subcellular NAD(+) pools are interconnected and buffered by mitochondrial NAD()
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study used engineered cell lines (species not specified) stably expressing PARP activity in mitochondria, the cytosol, endoplasmic reticulum, or peroxisomes to study subcellular NAD+ pools, combined with isotope-tracer flux measurements and mathematical modelling. Compartment-specific NAD+ overconsumption reduced cellular NAD+ concentrations by up to 50%, and the authors report that the lowered concentration kinetically restricted further NAD+ consumption to balance an unchanged biosynthesis rate. This chronic NAD+ deficiency caused no apparent effect except when mitochondria were directly targeted. The authors describe mitochondria as maintaining NAD+ via import through SLC25A51 and reversible cleavage to nicotinamide mononucleotide and ATP via NMNAT3, acting as a buffer for subcellular NAD+ pools.
Abstract
The coenzyme NAD+ is consumed by signalling enzymes, including poly-ADP-ribosyltransferases (PARPs) and sirtuins. Ageing is associated with a decrease in cellular NAD+ levels, but how cells cope with persistently decreased NAD+ concentrations is unclear. Here, we show that subcellular NAD+ pools are interconnected, with mitochondria acting as a rheostat to maintain NAD+ levels upon excessive consumption. To evoke chronic, compartment-specific overconsumption of NAD+, we engineered cell lines stably expressing PARP activity in mitochondria, the cytosol, endoplasmic reticulum or peroxisomes, resulting in a decline of cellular NAD+ concentrations by up to 50%. Isotope-tracer flux measurements and mathematical modelling show that the lowered NAD+ concentration kinetically restricts NAD+ consumption to maintain a balance with the NAD+ biosynthesis rate, which remains unchanged. Chronic NAD+ deficiency is well tolerated unless mitochondria are directly targeted. Mitochondria maintain NAD+ by import through SLC25A51 and reversibly cleave NAD+ to nicotinamide mononucleotide and ATP when NMNAT3 is present. Thus, these organelles can maintain an additional, virtual NAD+ pool. Our results are consistent with a well-tolerated ageing-related NAD+ decline as long as the vulnerable mitochondrial pool is not directly affected.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.